Hepatitis C Treatment Snapshots: Daclatasvir

Hepatitis C Treatment Snapshots: Daclatasvir

For a simplified snapshot from TREAT Asia/amfAR on daclatasvir, a second generation direct-acting antiviral for the treatment of hepatitis C, please click here.

/ News

Share the Post

Related Posts

Asia-Pacific Aids Groups Express Deep Dismay At Conclusion Of Secretly Negotiated Trans-Pacific Partnership Agreement That Threatens Future Access To Affordable Generic Medicines And Sustainable Development Goals
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
Part 1: What is hepatitis C and how is it diagnosed?
Community group taking actions to enable greater access for generic HCV treatment
BMS’ patent bid for Hep C treatment Daclatasvir Challenged
Asia Pacific Situational Updates on Generic DAAs – June 2017
Part 2: How is hepatitis C treated?
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment